Bronx, New York 10461


Purpose:

Chronic pain is a major public health problem that places many burdens on individuals, including impairment of physical and psychological functioning, lost productivity, and side effects of medications used to treat pain. There is also substantial evidence that minority populations differ both in prevalence and outcomes of chronic pain; access to care is a key component in these differences. Strong evidence now supports the use of acupuncture in the treatment of chronic pain conditions, including when provided in the primary care setting to patients from ethnically diverse, medically underserved populations. Acupuncture is slowly being integrated into pain management in many conventional health care settings, but cost and reimbursement for this service remain obstacles to offering acupuncture, especially in primary care and safety net settings. Because group acupuncture can be offered at much lower cost, demonstrating that individual and group delivery are equally effective could reduce barriers to use of this effective pain management approach. The primary aim of this study will be to evaluate whether acupuncture delivered in the group setting for patients with chronic pain is equal to acupuncture delivered in the individual setting. A secondary objective will be to use qualitative analysis to understand and describe the patient experience of both acupuncture approaches, and to utilize this data to inform intervention delivery and dissemination, to better incorporate the patient perspective.


Criteria:

Inclusion Criteria: - Referred by a primary care provider from one of our participating primary care health centers - Provider-documented diagnosis of osteoarthritis (any joint), neck pain, OR back pain - Self-reported pain score of ≥4 for at least 3 months prior to program entry - Able to provide consent for treatment and data collection in either English or Spanish Exclusion Criteria: - < 21 years of age - Chronic pain not documented OR self reported pain of ≥4 for less than 3 months. - Currently taking oral or injectable anticoagulants. - Lack of contact information OR unavailable for duration of entire treatment period (24 weeks) - Inability to consent to treatment and data collection. - Active psychosis - Active substance abuse


NCT ID:

NCT02456727


Primary Contact:

Principal Investigator
M. Diane McKee, MD, MS
Albert Einstein College of Medicine of Yeshiva University

Eric N Gil, BA
Phone: 718-430-2599
Email: eric.gil@einstein.yu.edu


Backup Contact:

Email: claudia.lechuga@einstein.yu.edu
Claudia Lechuga, MS
Phone: 718-430-2023


Location Contact:

Bronx, New York 10461
United States

Claudia Lechuga, MS
Phone: 718-430-2023
Email: claudia.lechuga@einstein.yu.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.